CYP17A1 inhibitor

Blocks androgen synthesis in prostate cancer

Drugs with this mechanism (1)

Abiraterone — CYP17 inhibitor blocking androgen synthesis for prostate cancer; given with prednisone.

All mechanisms · Open the interactive console ↗